Statement Of Changes In Equity [Abstract]

Sopharma AD - Filing #6022427

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Dividends recognised as distributions to owners of parent, relating to prior years
8,798,000 BGN
- BGN
8,798,000 BGN
- BGN
- BGN
- BGN
- BGN
- BGN
- BGN
8,798,000 BGN
- BGN
Dividends recognised as distributions to owners of parent, relating to current year
5,032,000 BGN
- BGN
5,032,000 BGN
- BGN
- BGN
- BGN
- BGN
- BGN
- BGN
5,032,000 BGN
- BGN
Dividends recognised as distributions to non-controlling interests
6,617,000 BGN
- BGN
- BGN
- BGN
- BGN
- BGN
- BGN
- BGN
6,617,000 BGN
- BGN
- BGN
Increase (decrease) through transfer to statutory reserve, equity
- BGN
- BGN
2,866,000 BGN
- BGN
- BGN
- BGN
- BGN
- BGN
- BGN
- BGN
2,866,000 BGN
- BGN
- BGN
4,038,000 BGN
- BGN
4,038,000 BGN
- BGN
- BGN
- BGN
- BGN
- BGN
- BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.